Last updated on November 2019

A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma


Brief description of study

The purpose of this study is to determine whether nivolumab in combination with relatlimab is more effective than nivolumab by itself in treating unresectable melanoma or melanoma that has spread

Clinical Study Identifier: NCT03470922

Find a site near you

Start Over

Local Institution

Salzburg, Austria
0.84miles
  Connect »